345
Participants
Start Date
November 30, 2013
Primary Completion Date
August 31, 2026
Study Completion Date
January 31, 2027
Alpha-1 MP
0.9% Sodium Chloride for Injection, USP
New Zealand Respiratory and Sleep institute, Auckland
St Vincent's Hospital Sydney, Sydney
"Institutul de Ftiziopneumologie Chiril Draganiuc", Chisinau
Gentofte Hospital, Hellerup
St Vincent's Hospital Melbourne, Fitzroy
Waikato Hospital, Hamilton
The Prince Charles Hospital, Chermside
Centro Dr. Lazaro Langer, Córdoba
Royal Adelaide Hospital, Adelaide
Institute for Respiratory Health Inc, Nedlands
Århus Universitetshospital, Arhus C
Christchurch Hospital NZ, Christchurch
Karolinska Universitetssjukhuset, Solna, Stockholm
North Estonia Medical Centre Foundation, Tallinn
Penn State Univ. Milton S. Hershey Medical Center, Hershey
Skånes Universitetssjukhus, Malmö, Malmo
Turku University Central Hospital, Department of Pulmonary Diseases, Turku
Accellacare, Wilmington
Medical University of South Carolina, Charleston
University of Florida, Gainesville
Hospital Universitario Central de Asturias, Oviedo
University of Miami Miller School of Medicine, Miami
Groupe Hospitalier Sud - Hôpital Haut-Lévêque, Pessac
Medical Research of Central Florida, LLC, Leesburg
Universitaetsklinikum Giessen und Marburg GmbH, Marburg
Sahlgrenska Sjukhuset, Gothenburg
Ruhrlandklinik, Essen
Hospital de Cruces, Barakaldo
Tartu University Hospital, Tartu
Washington University School of Medicine, St Louis
Univer des Saarlandes Innere, Homburg Saar
Universitaetsklinikum Heidelberg, Heidelberg
Hôpital Cardio-Vasculaire et Pneumologique Louis Pradel, Bron
University of Texas Health Center at Tyler, Tyler
St. Joseph's Hospital and Medical Center, Phoenix
Oregon Health & Science University, Portland
FSI Scientific Research Institute of Pulmonology, Moscow
"SAIH of Yaroslavl region Clinical Hospital of Emergency Medical Care n.a. N. V. Solovyev", Yaroslavl
Spitalul Clinic de Boli Infectioase si Pneumoftiziologie, Timișoara
Clinic Dr.G Curteanu Oradea, Oradea
SBEI HPE Altai State Medical University of MoH and SD, Barnaul
Hospital del Torax Dr. Antonio A. Cetrangolo, Vicente López
Faculdade de Medicina do ABC, Santo André
UNIFESP - Universidade Federal de São Paulo, São Paulo
Instituto do Coração - Incor- HCFMUSP, São Paulo
Health Sciences Centre, St. John's
Queen Elizabeth II Health Sciences Centre, Halifax
Inspiration Research Limited, Toronto
SPZOZ Szpital Uniwersytecki w Krakowie, Krakow
Instytut Gruzlicy i Chorob Pluc w Warszawie, Warsaw
CTC - Clinical Trial Consultants AB, Linköping
CTC Clinical Trial Consultants AB, Uppsala
Lead Sponsor
Grifols Therapeutics LLC
INDUSTRY